ENANTA PHARMACEUTICALS, INC Payments of Stock Issuance Costs
ENANTA PHARMACEUTICALS, INC (ENTA) reported Payments of Stock Issuance Costs of $3.54 million for the 12-month period ending 2013-09-30, per its 10-K filed 2015-12-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2015-12-11
- ENANTA PHARMACEUTICALS, INC payments of stock issuance costs for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC payments of stock issuance costs for the quarter ending 2013-06-30 was $1.47M.
- ENANTA PHARMACEUTICALS, INC payments of stock issuance costs for the quarter ending 2013-03-31 was $688.00K.
- ENANTA PHARMACEUTICALS, INC payments of stock issuance costs for the quarter ending 2012-12-31 was $1.39M.
- ENANTA PHARMACEUTICALS, INC payments of stock issuance costs for fiscal 2013 was $3.54M, a 237.14% increase from fiscal 2012.
- ENANTA PHARMACEUTICALS, INC payments of stock issuance costs for fiscal 2012 was $1.05M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2013-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $1.47M derived: sum of 2 quarters · filed 2015-12-11 | $2.15M derived: sum of 3 quarters · filed 2015-12-11 | $3.54M 10-K · filed 2015-12-11 |
| 2013-06-30 | $1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12 | $2.15M derived: sum of 2 quarters · filed 2014-08-12 | $3.54M 10-Q · filed 2014-08-12 | $4.55M derived: sum of 4 quarters · filed 2014-12-11 |
| 2013-03-31 | $688.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12 | $2.07M 10-Q · filed 2014-05-12 | $3.08M derived: sum of 3 quarters · filed 2014-12-11 | |
| 2012-12-31 | $1.39M 10-Q · filed 2014-02-13 | $2.39M derived: sum of 2 quarters · filed 2014-12-11 | ||
| 2012-09-30 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-11 | $1.05M 10-K · filed 2014-12-11 | ||
| 2012-06-30 | $44.00K 10-Q · filed 2013-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |